Home › NDC Lookup › RxCUI directory › RxCUI 1944704

Gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg] — RxCUI 1944704

RxNorm drug concept · Semantic branded drug
RxCUI 1944704 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1944704
Official nameGemtuzumab ozogamicin 4.5 MG Injection [Mylotarg]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMylotarg 4.5 MG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gemtuzumab Ozogamicin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats CD33-positive acute myeloid leukemia (AML). That includes newly diagnosed AML in adults and children 1 month and older. It also includes AML that has come back or not res...
  • It is given through a vein (IV infusion) by your healthcare team. Beforehand, you will get a steroid, an antihistamine, and acetaminophen to lower the chance of a reaction. Your te...
  • Common ones include bleeding, infection, fever, nausea, vomiting, constipation, headache, rash, mouth sores, and low appetite. Your team will watch your blood counts and liver test...
  • Call for fever or chills, trouble breathing, or dizziness during or after an infusion. Also call for unusual bleeding, painful belly swelling, rapid weight gain, or yellow skin or...
📖 Read our full Gemtuzumab Ozogamicin Injection guide →

🕸️ Concept Web — How Gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg] RxCUI 1944704

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gemtuzumab ozogamicin 1294580
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mylotarg 261585
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gemtuzumab ozogamicin Injection 1944700
    • Gemtuzumab ozogamicin Injectable Product 1294582
    • Gemtuzumab ozogamicin Injection [Mylotarg] 1944703
    • Mylotarg Injectable Product 1185673
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gemtuzumab ozogamicin 4.5 MG Injection SCD · 1944701
  • Gemtuzumab ozogamicin 4.5 MG SCDC · 1944699
  • Gemtuzumab ozogamicin Injection SCDF · 1944700
  • Gemtuzumab ozogamicin Injectable Product SCDG · 1294582

Brand-Name Concepts

  • Gemtuzumab ozogamicin 4.5 MG [Mylotarg] SBDC · 1944702
  • Gemtuzumab ozogamicin Injection [Mylotarg] SBDF · 1944703
  • Mylotarg Injectable Product SBDG · 1185673
  • Mylotarg BN · 261585

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1944704 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00008-4510-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0008-4510-01) / 5 mL in 1... Mylotarg Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 2017-09-07
Observed labelers: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9203 Gemtuzumab ozogamicin 0.1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.